Le Lézard
Classified in: Science and technology
Subject: OBI

Pivot Technology Solutions, Inc. Mourns Death of Board Member Douglas Stuve


TORONTO, Nov. 27, 2017 /CNW/ - Pivot Technology Solutions, Inc. (TSX: PTG), ("Pivot" or the "Company") today announced the passing of Douglas Murray Stuve, a valued friend and dedicated member of the Company's Board of Directors. Mr. Stuve was 49 years old.

Mr. Stuve became a member of Pivot's Board of Directors in 2012 and served in a similar capacity at several public and private companies. He was also a member of the advisory committees of the TSX Venture Exchange and the Alberta Stock Exchange.

"Doug was a respected member of the Canadian legal community, and an excellent business advisor but an even better friend to all who had the privilege of knowing him," said Kevin Shank, President and Chief Executive Officer. "On behalf of everyone at Pivot, we send our deepest sympathies to Doug's immediate and extended family."

About Pivot Technology Solutions, Inc.
Pivot is an industry leading information technology services and solutions provider to many of the world's most successful companies, including members of the Fortune 1000, as well as governments and educational institutions. By leveraging its extensive OEM partnerships and its own fulfillment, professional, deployment, workforce and managed services, Pivot supports the IT infrastructure needs of its clients. For more information, visit www.pivotts.com.

SOURCE Pivot Technology Solutions, Inc


These press releases may also interest you

at 07:40
Avicanna Inc. ("Avicanna" or the "Company) a biopharmaceutical company focused on the development, manufacturing, and commercialization of...

at 07:35
Cybin Inc. (Cboe CA:CYBN) ("Cybin" or the "Company"), a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by developing new and innovative next-generation psychedelic treatment options, is pleased to announce...

at 07:35
Syros Pharmaceuticals , a biopharmaceutical company committed to advancing new standards of care for the frontline treatment of hematologic malignancies, today reported financial results for the quarter ended March 31, 2024 and provided a corporate...

at 07:35
Zai Lab Limited today announced that the Center for Drug Evaluation (CDE) of the China National Medical Products Administration (NMPA) has accepted the supplemental Biologics License Application (sBLA) for efgartigimod alfa injection (subcutaneous...

at 07:35
SolarWinds , a leading provider of simple, powerful, secure observability and IT management software, today announced significant enhancements for SolarWinds® Database Performance Analyzer (DPA) to provide enterprises with greater visibility and...

at 07:35
Calliditas Therapeutics AB   ("Calliditas") today announces that its partner Everest Medicines (HKEX: 1952.HK) ("Everest") has launched Nefecon® in China. China, which is estimated to have up to 5 million patients suffering from the progressive...



News published on and distributed by: